Abstract:Introduction: A deadly gynecological cancer, ovarian cancer (OV), has a poor prognosis because of late-stage diagnosis and few targeted therapies. Addressing the tumor microenvironment (TME) in solid tumors has shown promise since it is crucial in promoting cancer progression. Methods: We obtained bulk RNA-seq data from TCGA-OV, GSE26712, GSE102073, and ICGC cohorts, as well as scRNA-seq data from EMTAB8107, GSE118828, GSE130000, and GSE154600 cohorts using the TISCH2 database. The ConsensusClusterPlus package was used to cluster the OV tumor tissues hierarchically to determine two molecularly different groups (C1 and C2). A total of ten different types of machine learning techniques with 101 combinations were used for prognostic model construction. Using eight TME algorithms integrated into the IOBR R package, the bulk RNA-seq dataset was analyzed. For in vitro experiments, OVCAR3 and SKOV3, two OV cell lines, were used. The migratory potential of the ovarian cancer cells was assessed using Transwell assay, while proliferation was assessed using CCK8 assay. Results: Based on TME-related gene set expression, two distinct molecular subgroups (C1 and C2) were identified through consensus clustering, with C1 showing higher TME activity. Further analysis indicated that C1 had increased cancer-associated fibroblasts (CAFs), M1 macrophages, and CD8+ T cells, suggesting a more activated and pro-inflammatory TME. Drug sensitivity analysis revealed that 5-Fluorouracil might be beneficial to C1 patients. Functional differences between C1 and C2 were identified, including cell adhesion, mononuclear cell differentiation, and leukocyte migration. A machine learning model was developed to create a TME-related prognostic signature, demonstrating strong prognostic capabilities across multiple datasets. High-risk patients showed a more immune-suppressive TME and higher tumor stemness. ScRNA-seq disclosed a highly activated TME-related signature in OV. Cancer cell lines had significantly higher SH2D1A mRNA expression than normal ovarian epithelial cells. We observed that SH2D1A knockdown in 2 ovarian cancer cell lines (OVCAR3 and SKOV3) reduced migration and proliferation through a series of in-vitro experiments. Conclusion: TME-associated genes were efficient in ovarian cancer molecular subtyping. A TME-based prognosis model was constructed for vigorous prognostic stratification efficacy across multiple datasets. Moreover, we identified a pivotal role of SH2D1A in promoting proliferation and migration in ovarian cancer.

Β-Catenin/tcf4-induced SCUBE3 Upregulation Promotes Ovarian Cancer Development Via HIF-1 Signaling Pathway

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

E2F2 Induces MCM4, CCNE2 and WHSC1 Upregulation in Ovarian Cancer and Predicts Poor Overall Survival.

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

SCUBE3 exerts a tumor-promoting effect in tongue squamous cell carcinoma by promoting CEBPA binding to the CCL2 promoter

Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis

TPPP3 Inhibits the Proliferation, Invasion and Migration of Endometrial Carcinoma Targeted with Mir-1827

Effects of Dynein Light Chain Tctex-type 3 on the Biological Behavior of Ovarian Cancer

CXXC5 Drove Inflammation and Ovarian Cancer Proliferation Via Transcriptional Activation of ZNF143 and EGR1

Ctcf Promotes Epithelial Ovarian Cancer Metastasis by Broadly Controlling the Expression of Metastasis-Associated Genes

[Role of SCUBE3 in Promoting Osteosarcoma Cell Growth and Its Association with Prognosis].

TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis

CircUBE2D2 regulates HMGB1 through miR-885-5p to promote ovarian cancer malignancy

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

Sex-determining Region Y-box3 (SOX3) Functions As an Oncogene in Promoting Epithelial Ovarian Cancer by Targeting Src Kinase

A Comprehensive Bioinformatics Analysis to Identify a Candidate Prognostic Biomarker for Ovarian Cancer

The Overexpression of Acyl-CoA Medium-Chain Synthetase-3 (ACSM3) Suppresses the Ovarian Cancer Progression Via the Inhibition of Integrin Β1/akt Signaling Pathway

Screening and identification of key biomarkers and related transcription factors in ovarian cancer by integrated bioinformatics analysis

UBP43 Promotes Epithelial Ovarian Carcinogenesis Via Activation of Β‐catenin Signaling Pathway

CpG-binding Protein CFP1 Promotes Ovarian Cancer Cell Proliferation by Regulating BST2 Transcription

CENPK Orchestrates Ovarian Cancer Progression Via GOLPH3-Mediated Activation of Mtor Signaling